The Real AIDS Epidemic - Culshaw, Rebecca V.
31,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 2-4 Wochen
payback
16 °P sammeln
  • Gebundenes Buch

Four decades after And the Band Played On created an image of the AIDS epidemic that has survived in the public consciousness to this very day, mathematician Rebecca Culshaw is sounding the alarm that everything that iconic book told us about AIDS is demonstrably wrong. And that mistaken understanding of AIDS and its cause has the potential to affect all of us, not just certain so-called risk groups. In The Real AIDS Epidemic, Rebecca Culshaw describes her slow uncovering of these reasons over her years researching HIV for her work constructing mathematical models of its interaction with the…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Four decades after And the Band Played On created an image of the AIDS epidemic that has survived in the public consciousness to this very day, mathematician Rebecca Culshaw is sounding the alarm that everything that iconic book told us about AIDS is demonstrably wrong. And that mistaken understanding of AIDS and its cause has the potential to affect all of us, not just certain so-called risk groups. In The Real AIDS Epidemic, Rebecca Culshaw describes her slow uncovering of these reasons over her years researching HIV for her work constructing mathematical models of its interaction with the immune system. It is rare that a researcher, having studied HIV, ever expresses any doubt in the paradigm, and an even rarer event still when she abandons the field altogether. Culshaw's book, updated from its original edition, which was titled Science Sold Out, is one of the great insider-turned-whistleblower stories of our time.   The Real AIDS Epidemic focuses on the politics of the changing definition of AIDS and the flaws in all HIV testing. In a much broader sense, it explains how the current, government-based structure of scientific research has corrupted science as the search for truth. It offers not only scientific reasons for HIV/AIDS being untenable, but also sociological explanations as to how the theory was accepted by the media and the world so quickly. In particular, this book offers a scathing criticism of the outrageous discriminatory measures that have been leveled at HIV-positives from the inception. She also warns that the toxic drugs being foisted on the Black and gay communities constitute one of the worst medical violations of human rights since the Tuskegee Syphilis Experiment.    The compelling case she makes that the AIDS establishment has led us into a biomedical disaster through incompetence, fraud, and deceit will have many readers throwing their hands up and feeling helpless and hopeless. But she does something no other book that is critical about HIV and AIDS has done. She suggests a series of strategic actions the scientific community, Congress, the media, and the public can take to undo the damage that the powerful AIDS establishment has done since the epidemic began in 1981.  
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Rebecca Culshaw came to the US in 2002, after receiving her PhD in mathematics from Dalhousie University in Halifax, Canada. She has published several journal articles regarding mathematical modeling of HIV immunology and served on the Advisory Board of Journal of Biological Systems. Culshaw has resided in Iowa, Nova Scotia, London, Ottawa, and Mzuzu, Malawi, and currently lives in Tyler, Texas. Neenyah Ostrom’s groundbreaking reporting on AIDS and the chronic fatigue syndrome epidemic appeared in the New York Native from 1988 to 1997. For revealing the unreliability of the HIV antibody test, Ostrom and New York Native were recognized for reporting one of the top twenty-five most-censored stories in the US press by 1995’s Censored: The News That Didn’t Make The News—And Why (The 1995 Project Censored Yearbook). Ostrom is the author of four books about AIDS and its link to the chronic fatigue syndrome epidemic, including 2022’s Ampligen: The Battle for a Promising ME/CFS Drug.